Scientists have developed a new technology for designing mirror-image versions of molecules, paving the way for longer lasting medicines. For patients, this would mean less frequent injections and more drugs could one day be developed in a pill form. They show the method works by creating mirror image versions of blockbuster diabetes and osteoporosis drugs, GLP1 and PTH, respectively, which had longer lasting effects as expected.